Primary Immune Deficiency Disorders (PIDD)

DBCOND0038807Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesImmune System Diseases

Primary Immune Deficiency Disorders (PIDD) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Primary Immunodeficiency (PID) · Primary Immunodeficiency Disorders · Primary Immune Deficiency · Primary Immune Deficiency (PID) · Primary Immune Deficiency Disease (PIDD)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000650094SNOMED CT36138009MedDRA10036700UMLSC0272229

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
148Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Primary Immune Deficiency Disorders (PIDD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In